Cargando…
Dihydromyricetin Attenuates Cerebral Ischemia Reperfusion Injury by Inhibiting SPHK1/mTOR Signaling and Targeting Ferroptosis
BACKGROUND: Dihydromyricetin (DHM) exerts protective effects in various brain diseases. The aim of this research was to investigate the biological role of DHM in cerebral ischemia reperfusion (I/R) injury. METHODS: We generated a rat model of cerebral I/R injury by performing middle cerebral artery...
Autores principales: | Xie, Jiangbo, Zhang, Tingting, Li, Peichun, Wang, Dong, Liu, Tao, Xu, Shunliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477154/ https://www.ncbi.nlm.nih.gov/pubmed/36118165 http://dx.doi.org/10.2147/DDDT.S378786 |
Ejemplares similares
-
The role of mTOR signaling pathway on cognitive functions in cerebral ischemia-reperfusion
por: Yang, Liying, et al.
Publicado: (2017) -
Eugenol Attenuates Cerebral Ischemia-Reperfusion Injury by Enhancing Autophagy via AMPK-mTOR-P70S6K Pathway
por: Sun, Xiaowei, et al.
Publicado: (2020) -
Snapshot: Implications for mTOR in Aging-related Ischemia/Reperfusion Injury
por: Liu, Dong, et al.
Publicado: (2019) -
Crosstalk between TLR2 and Sphk1 in microglia in the cerebral ischemia/reperfusion-induced inflammatory response
por: Sun, Wei, et al.
Publicado: (2017) -
mTOR/autophagy pathway in the hippocampus of rats suffering intermittent hypoxia preconditioning and global cerebral ischemia-reperfusion
por: Zhao, Ya-Ning, et al.
Publicado: (2017)